Skip to main content
Top
Published in: Clinical Rheumatology 1/2015

Open Access 01-03-2015 | Review Article

Challenges faced in Latin America for the implementation of an ideal health-care model for rheumatoid arthritis patients: are we ready?

Authors: Juan Carlos Rodríguez Jaillier, Ana María Posada Arango, David Antonio Martínez Pérez

Published in: Clinical Rheumatology | Special Issue 1/2015

Login to get access

Abstract

Rheumatoid arthritis (RA) is a chronic, inflammatory, progressive disease characterized by inflammation of the synovial tissue. It results in the severe functional deterioration of the joints involved and the incapacity to work. Our main aim is to determine the characteristics of the current health-care models used in treating rheumatoid arthritis patients in Latin America. We want to analyze the details, using them as the foundation to create an ideal health-care model that is focused on the patient. We have revised documents, including guides to clinical practice, monitoring models and health-care models according to the current policies and resources available in various Latin American countries. Based on this information, the qualities and deficiencies of the current models will be analyzed, in order to use this as a basis on which to construct a proposed health-care model that covers the specific needs of rheumatoid arthritis patients, considering the resources of each population. Despite the collapse seen in many health systems throughout history, we can learn from them and should develop a new model starting from the path pursued, capitalizing on our experiences, teachings, and errors committed. However, in most cases, the obstacles to the success of the systems do not lie in the fundamental structure or the “spirit of the legislator” but rather in the day-to-day development within the community and the special interest of each agent in a system.
Literature
1.
go back to reference Emery P, Breedveld FC, Dougados M, Kalden JR, Schiff MH, Smolen JS (2002) Early referral recommendation for newly diagnosed rheumatoid arthritis: evidence based development of a clinical guide. Ann Rheum Dis 61:290–297PubMedCentralCrossRefPubMed Emery P, Breedveld FC, Dougados M, Kalden JR, Schiff MH, Smolen JS (2002) Early referral recommendation for newly diagnosed rheumatoid arthritis: evidence based development of a clinical guide. Ann Rheum Dis 61:290–297PubMedCentralCrossRefPubMed
2.
go back to reference Solomon DH, Bates DW, Panush RS, Katz JN (1997) Costs, outcomes, and patient satisfaction by provider type for patients with rheumatic and musculoskeletal conditions: a critical review of the literature and proposed methodologic standards. Ann Intern Med 127:52–60CrossRefPubMed Solomon DH, Bates DW, Panush RS, Katz JN (1997) Costs, outcomes, and patient satisfaction by provider type for patients with rheumatic and musculoskeletal conditions: a critical review of the literature and proposed methodologic standards. Ann Intern Med 127:52–60CrossRefPubMed
3.
go back to reference Ambriz Murillo Y, Menor Almagro R, Campos-González ID, Cardiel MH (2015) Health related quality of life in rheumatoid arthritis, osteoarthritis, diabetes mellitus, end stage renal disease and geriatric subjects. Experience from a general hospital in Mexico. Reumatol Clin 11(2):68–72. doi:10.1016/j.reuma.2014.03.006 CrossRefPubMed Ambriz Murillo Y, Menor Almagro R, Campos-González ID, Cardiel MH (2015) Health related quality of life in rheumatoid arthritis, osteoarthritis, diabetes mellitus, end stage renal disease and geriatric subjects. Experience from a general hospital in Mexico. Reumatol Clin 11(2):68–72. doi:10.​1016/​j.​reuma.​2014.​03.​006 CrossRefPubMed
4.
go back to reference Daniel Roig V, Montserrat Nuñez Juárez B, Esther Nuñez Juárez C, José Luis Del Val García C, Alex Sánchez P, Maria Bonet L, En nombre del grupo ARQUALIS1 (2009) Characterization of patients with rheumatoid arthritis according to the health care level. Reumatol Clin 5(4):153–157CrossRef Daniel Roig V, Montserrat Nuñez Juárez B, Esther Nuñez Juárez C, José Luis Del Val García C, Alex Sánchez P, Maria Bonet L, En nombre del grupo ARQUALIS1 (2009) Characterization of patients with rheumatoid arthritis according to the health care level. Reumatol Clin 5(4):153–157CrossRef
5.
go back to reference Carlo Vinicio Caballero U (2004) Artritis reumatoide como enfermedad de alto costo. Rev Colomb Reumatol 11(3):225–231 Carlo Vinicio Caballero U (2004) Artritis reumatoide como enfermedad de alto costo. Rev Colomb Reumatol 11(3):225–231
6.
go back to reference Vol. 11 – Núm. 2 – Febrero 2001 MEDIFAM 2001; 11: 47-54 ARTÍCULO ESPECIAL Gestión de Enfermedades (Disease Management). Una aproximación integral a la provisión de cuidados sanitarios Vol. 11 – Núm. 2 – Febrero 2001 MEDIFAM 2001; 11: 47-54 ARTÍCULO ESPECIAL Gestión de Enfermedades (Disease Management). Una aproximación integral a la provisión de cuidados sanitarios
7.
go back to reference Mustafa Al M, Femi A, Jamal Al S, Yousef Al W, Gerd-Rüdiger B, Maurizio C, Joseph F, Lyn M, Heather MD-B, Kevin P, Carlos P, Carter T, Kvien TK (2015) The global challenges and opportunities in the practice of rheumatology: white paper by the world forum on rheumatic and musculoskeletal diseases. Clin Rheumatol. doi:10.1007/s10067-014-2841-6 Mustafa Al M, Femi A, Jamal Al S, Yousef Al W, Gerd-Rüdiger B, Maurizio C, Joseph F, Lyn M, Heather MD-B, Kevin P, Carlos P, Carter T, Kvien TK (2015) The global challenges and opportunities in the practice of rheumatology: white paper by the world forum on rheumatic and musculoskeletal diseases. Clin Rheumatol. doi:10.​1007/​s10067-014-2841-6
8.
go back to reference Skouen JA, Grasdal A, Haldorsen EMH (2006) Return to work after comparing outpatient patient multidisciplinary treatment programs versus treatment in general practice for patients with chronic widespread pain. Eur J Pain 10:145–152CrossRefPubMed Skouen JA, Grasdal A, Haldorsen EMH (2006) Return to work after comparing outpatient patient multidisciplinary treatment programs versus treatment in general practice for patients with chronic widespread pain. Eur J Pain 10:145–152CrossRefPubMed
9.
go back to reference Cardiel MH, Díaz-Borjón A, del Mercado Espinosa MV, Gámez-Nava JI, Barile Fabris LA, Pacheco Tena C, Silveira Torre LH, Pascual Ramos V, Goycochea Robles MV, Aguilar Arreola JE, González Díaz V, Alvarez Nemegyei J, del González-López LC, Salazar Áramo M, Portela Hernández M, Castro Colín Z, Xibillé Friedman DX, Alvarez Hernández E, Casasola Vargas J, Cortés Hernández M, Flores-Alvarado DE, Martínez Martínez LA, Vega-Morales D, Flores-Suárez LF, Medrano Ramírez G, Barrera Cruz A, García González A, López López SM, Rosete Reyes A, Espinosa Morales R (2014) Update of the Mexican College of Rheumatology guidelines for the pharmacologic treatment of rheumatoid arthritis. Reumatol Clin 10(4):227–240. doi:10.1016/j.reuma.2013.10.006 CrossRefPubMed Cardiel MH, Díaz-Borjón A, del Mercado Espinosa MV, Gámez-Nava JI, Barile Fabris LA, Pacheco Tena C, Silveira Torre LH, Pascual Ramos V, Goycochea Robles MV, Aguilar Arreola JE, González Díaz V, Alvarez Nemegyei J, del González-López LC, Salazar Áramo M, Portela Hernández M, Castro Colín Z, Xibillé Friedman DX, Alvarez Hernández E, Casasola Vargas J, Cortés Hernández M, Flores-Alvarado DE, Martínez Martínez LA, Vega-Morales D, Flores-Suárez LF, Medrano Ramírez G, Barrera Cruz A, García González A, López López SM, Rosete Reyes A, Espinosa Morales R (2014) Update of the Mexican College of Rheumatology guidelines for the pharmacologic treatment of rheumatoid arthritis. Reumatol Clin 10(4):227–240. doi:10.​1016/​j.​reuma.​2013.​10.​006 CrossRefPubMed
10.
go back to reference Álvarez-Hernández E, Peláez-Ballestas I, Boonen A, Vázquez-Mellado J, Hernández-Garduño A, Rivera FC, Teran-Estrada L, Ventura-Ríos L, Ramos-Remus C, Skinner-Taylor C, Goycochea-Robles MV, Bernard-Medina AG, Burgos-Vargas R (2012) Catastrophic health expenses and impoverishment of households of patients with rheumatoid arthritis. Reumatol Clin 8(4):168–173. doi:10.1016/j.reuma.2012.05.002 CrossRefPubMed Álvarez-Hernández E, Peláez-Ballestas I, Boonen A, Vázquez-Mellado J, Hernández-Garduño A, Rivera FC, Teran-Estrada L, Ventura-Ríos L, Ramos-Remus C, Skinner-Taylor C, Goycochea-Robles MV, Bernard-Medina AG, Burgos-Vargas R (2012) Catastrophic health expenses and impoverishment of households of patients with rheumatoid arthritis. Reumatol Clin 8(4):168–173. doi:10.​1016/​j.​reuma.​2012.​05.​002 CrossRefPubMed
11.
go back to reference Stoffer MA, Smolen JS, Anthony W, Ales A, Ailsa B, Loreto C, Veronika F-M, Estibaliz L, Pawel O, Petersson IF, Till U, Stamm TA, the eumusc.net-working group (2014) Development of patient-centred standards of care for rheumatoid arthritis in Europe: the eumusc.net project. Ann Rheum Dis 73:902–905PubMedCentralCrossRefPubMed Stoffer MA, Smolen JS, Anthony W, Ales A, Ailsa B, Loreto C, Veronika F-M, Estibaliz L, Pawel O, Petersson IF, Till U, Stamm TA, the eumusc.net-working group (2014) Development of patient-centred standards of care for rheumatoid arthritis in Europe: the eumusc.net project. Ann Rheum Dis 73:902–905PubMedCentralCrossRefPubMed
12.
go back to reference Chan A, Felson TD, Yood AR, Walker MA (1994) The lag time between onset of symptoms and diagnosis of rheumatoid arthritis. Arthritis Rheum 37:814–819CrossRefPubMed Chan A, Felson TD, Yood AR, Walker MA (1994) The lag time between onset of symptoms and diagnosis of rheumatoid arthritis. Arthritis Rheum 37:814–819CrossRefPubMed
13.
go back to reference Hernández-García C, Vargas E, Abásolo L, Lajas C, Bellajdell B, Morado IC et al (2000) Lag time between onset of symptoms and access to rheumatology care and DMARD therapy in a cohort of patients with rheumatoid arthritis. J Rheumatol 27:2323–2328PubMed Hernández-García C, Vargas E, Abásolo L, Lajas C, Bellajdell B, Morado IC et al (2000) Lag time between onset of symptoms and access to rheumatology care and DMARD therapy in a cohort of patients with rheumatoid arthritis. J Rheumatol 27:2323–2328PubMed
14.
go back to reference Jamal S, Alibhai SM, Badley EM, Bombardier C (2011) Time to treatment for new patients with rheumatoid arthritis in a major metropolitan city. J Rheumatol 38:1282–1288CrossRefPubMed Jamal S, Alibhai SM, Badley EM, Bombardier C (2011) Time to treatment for new patients with rheumatoid arthritis in a major metropolitan city. J Rheumatol 38:1282–1288CrossRefPubMed
15.
go back to reference Kumar K, Daley E, Carruthers DM, Situnayake D, Gordon C, Grindulis K et al (2007) Delay in presentation to primary care physicians is the main reason why patients with rheumatoid arthritis are seen late by rheumatologists. Rheumatology (Oxford) 46:1438–1440CrossRef Kumar K, Daley E, Carruthers DM, Situnayake D, Gordon C, Grindulis K et al (2007) Delay in presentation to primary care physicians is the main reason why patients with rheumatoid arthritis are seen late by rheumatologists. Rheumatology (Oxford) 46:1438–1440CrossRef
16.
go back to reference Zafar S, Badsha H, Mofti A, Delosantos A, Altares J, Matudio G et al (2012) Efforts to increase public awareness may result in more timely diagnosis of rheumatoid arthritis. J Clin Rheumatol 18:279–282CrossRefPubMed Zafar S, Badsha H, Mofti A, Delosantos A, Altares J, Matudio G et al (2012) Efforts to increase public awareness may result in more timely diagnosis of rheumatoid arthritis. J Clin Rheumatol 18:279–282CrossRefPubMed
17.
go back to reference Raza K, Stack R, Kumar K, Filer A, Detert J, Bastian H et al (2011) Delays in assessment of patients with rheumatoid arthritis: variations across Europe. Ann Rheum Dis 182:2–5 Raza K, Stack R, Kumar K, Filer A, Detert J, Bastian H et al (2011) Delays in assessment of patients with rheumatoid arthritis: variations across Europe. Ann Rheum Dis 182:2–5
18.
go back to reference Muñoz Alamo M, Ruiz Moral R, Pérula de Torres LA (2002) Evaluation of a patient centred approach in generalized musculoskeletal chronic pain/fibromyalgia patients in primary care. Patient Educ Couns 48:23–31CrossRef Muñoz Alamo M, Ruiz Moral R, Pérula de Torres LA (2002) Evaluation of a patient centred approach in generalized musculoskeletal chronic pain/fibromyalgia patients in primary care. Patient Educ Couns 48:23–31CrossRef
19.
go back to reference Machado P, Castrejon I, Katchamart W, Koevoets R, Kuriya B, Schoels M et al (2011) Multinational evidence-based recommendations on how to investigate and follow-up undifferentiated peripheral inflammatory arthritis: integrating systematic literature research and expert opinion of a broad international panel of rheumatologists in the 3E Initiative. Ann Rheum Dis 70:15–24. doi:10.1136/ard.2010.130625 PubMedCentralCrossRefPubMed Machado P, Castrejon I, Katchamart W, Koevoets R, Kuriya B, Schoels M et al (2011) Multinational evidence-based recommendations on how to investigate and follow-up undifferentiated peripheral inflammatory arthritis: integrating systematic literature research and expert opinion of a broad international panel of rheumatologists in the 3E Initiative. Ann Rheum Dis 70:15–24. doi:10.​1136/​ard.​2010.​130625 PubMedCentralCrossRefPubMed
21.
go back to reference Van der Heide A, Jacobs JW, Biglsma WA, Heurkens AH, van Booma-Frankfort C, van der Veen MJ et al (1996) The effectiveness of early treatment with second line antirreheumatic drugs: a randomised controlled trial. Ann Intern Med 124:699CrossRefPubMed Van der Heide A, Jacobs JW, Biglsma WA, Heurkens AH, van Booma-Frankfort C, van der Veen MJ et al (1996) The effectiveness of early treatment with second line antirreheumatic drugs: a randomised controlled trial. Ann Intern Med 124:699CrossRefPubMed
22.
go back to reference Van der Linden MP, le Cessie S, Raza K, van der Woude D, Knevel R, Huizinga TW et al (2010) Long-term impact of delay in assessment of patients with early arthritis. Arthritis Rheum 62:3537–3546CrossRefPubMed Van der Linden MP, le Cessie S, Raza K, van der Woude D, Knevel R, Huizinga TW et al (2010) Long-term impact of delay in assessment of patients with early arthritis. Arthritis Rheum 62:3537–3546CrossRefPubMed
23.
go back to reference Mottonen R, Hammonnen P, Leirisalo- Rapo M, Nissila M, Kauntiamen H, Korpela M et al (1997) Comparison of combination therapy with single-drug therapy in early rheumatoid arthritis: a randomised trial. Lancet 350:309–318CrossRef Mottonen R, Hammonnen P, Leirisalo- Rapo M, Nissila M, Kauntiamen H, Korpela M et al (1997) Comparison of combination therapy with single-drug therapy in early rheumatoid arthritis: a randomised trial. Lancet 350:309–318CrossRef
24.
go back to reference Romero RV, Ramírez NA, Méndez PAM, Vélez OR (2009) Atención Primaria Integral de Salud, Estrategia para la Transformación del Sistema de Salud y el Logro de la Equidad en Salud, 1ra edición ISBN 978-958-8545-01-1 Bogotá D.C, Colombia Romero RV, Ramírez NA, Méndez PAM, Vélez OR (2009) Atención Primaria Integral de Salud, Estrategia para la Transformación del Sistema de Salud y el Logro de la Equidad en Salud, 1ra edición ISBN 978-958-8545-01-1 Bogotá D.C, Colombia
25.
go back to reference Manual de Acreditación en Salud Ambulatorio y Hospitalario Colombia (2011) ; Versión 003 Descriptores Acreditación—Accreditation Dirección General de Calidad de Servicios Unidad Sectorial de Normalización en Salud. Ministerio de la Protección Social - ISBN: 978-958-8717-33-3. Bogotá D.C, Colombia Manual de Acreditación en Salud Ambulatorio y Hospitalario Colombia (2011) ; Versión 003 Descriptores Acreditación—Accreditation Dirección General de Calidad de Servicios Unidad Sectorial de Normalización en Salud. Ministerio de la Protección Social - ISBN: 978-958-8717-33-3. Bogotá D.C, Colombia
26.
go back to reference Smolen JS, Robert L, Breedveld FC et al (2013) EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update. Ann Rheum Dis. doi:10.1136/annrheumdis-2013-204573 Smolen JS, Robert L, Breedveld FC et al (2013) EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update. Ann Rheum Dis. doi:10.​1136/​annrheumdis-2013-204573
27.
go back to reference Actualización de la guia de practica clinica para el manejo de la artritis reumatoide en España, GUIPCAR2007, Soc Esp Reumatol Actualización de la guia de practica clinica para el manejo de la artritis reumatoide en España, GUIPCAR2007, Soc Esp Reumatol
28.
go back to reference Latin American Rheumatology Associations of the Pan-American League of Associations for Rheumatology (PANLAR) and the Grupo Latinoamericano de Estudio de Artritis Reumatoide (GLADAR) (2006) First Latin American position paper on the pharmacological treatment of rheumatoid arthritis. Rheumatology 45:ii7–ii22. doi:10.1093/rheumatology/kei500 CrossRef Latin American Rheumatology Associations of the Pan-American League of Associations for Rheumatology (PANLAR) and the Grupo Latinoamericano de Estudio de Artritis Reumatoide (GLADAR) (2006) First Latin American position paper on the pharmacological treatment of rheumatoid arthritis. Rheumatology 45:ii7–ii22. doi:10.​1093/​rheumatology/​kei500 CrossRef
Metadata
Title
Challenges faced in Latin America for the implementation of an ideal health-care model for rheumatoid arthritis patients: are we ready?
Authors
Juan Carlos Rodríguez Jaillier
Ana María Posada Arango
David Antonio Martínez Pérez
Publication date
01-03-2015
Publisher
Springer London
Published in
Clinical Rheumatology / Issue Special Issue 1/2015
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-015-3034-7

Other articles of this Special Issue 1/2015

Clinical Rheumatology 1/2015 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.